Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.
17

Bausch + Lomb Successfully Defends Patent Covering PreserVision® Eye Vitamins in Case vs. Vitamin Health, Inc.

Court Finds Bausch + Lomb Patent to Be Valid, Enforceable and Infringed

FOR RELEASE TUESDAY, JANUARY 17, 2017  

 

BRIDGEWATER, NJ – Bausch + Lomb, a leading global eye health company, today announced it has resolved its patent infringement lawsuit vs. Vitamin Health, Inc., filed in September 2013 in the U.S. District Court for the Western District of New York.  Among other claims, the lawsuit accused Vitamin Health of infringing Bausch + Lomb’s U.S. patent 6,660,297 (the ‘297 patent) covering PreserVision® AREDS and AREDS 2 Formula eye vitamins through Vitamin Health’s manufacture and sale of certain of its Viteyes eye vitamins.

 

“We are pleased with the findings of the Court, which demonstrates the integrity of our PreserVision® AREDS and AREDS 2 Formula eye vitamins to meet the needs of eye care professionals and their patients,” said Joseph Gordon, senior vice president and general manager, Bausch + Lomb Consumer Healthcare. “As the leader in ocular nutrition, Bausch + Lomb is committed to providing the most current, science-based eye vitamin formulations. Therefore, when these or any of our products are infringed, we will vigorously defend our intellectual property and innovations to ensure our customers can continue to rely on products that are based on a robust body of scientific and clinical research.”  

 

On July 25, 2016, the Court issued a decision and order awarding summary judgment to Bausch + Lomb on its motion that certain of Vitamin Health’s AREDS-based formula and AREDS2-based formula eye vitamins infringed the ‘297 patent.  After proceeding to trial, the parties reached a settlement resolving other claims. 

 

As part of the settlement, the Court issued a consent decree on December 20, 2016, reflecting that Vitamin Health has admitted the ‘297 patent is valid and enforceable and that certain other of Vitamin Health’s AREDS and AREDS 2 Formula eye vitamins infringe the ‘297 patent.  Per the terms of the settlement, Vitamin Health has agreed to pay an undisclosed sum to Bausch + Lomb.

 

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Its core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.



PreserVision is a registered trademark of Bausch & Lomb Incorporated or its affiliates. AREDS2 is a registered trademark of The U.S. Department of Health and Human Services (HHS). Any other product/brand names are trademarks of their respective owners.
© 2017 Bausch & Lomb
Incorporated. PV2.0014.USA.17

 

News Media Contact:

Kristy Marks
Sr. Manager, Communications, Bausch + Lomb

(908) 927-0683 or kristy.marks@bausch.com

Actions: E-mail | Permalink |